12 Best Buy-the-Dip Stocks to Invest In Now

In this article, we will take a look at some of the best buy-the-dip stocks that are currently offering attractive upside potential. On June 5, CNBC reported that U.S. equities fell on Friday, weighed down by a sell-off in major chip stocks and rising Treasury yields following stronger-than-expected May jobs data. The Dow Jones Industrial Average dropped 491 points, or almost 1%. The S&P 500 dropped more than 2%, while the Nasdaq Composite took a dip of more than 3%, marking its biggest decline since April 2025. Broadcom, Marvell Technology, Micron Technology, Intel, and Advanced Micro Devices were among the semiconductor stocks that had the biggest drops, with losses ranging from 6% to 12%.

The Bureau of Labor Statistics reported that while the unemployment rate stayed at 4.3%, the non-farm payrolls rose by 172,000 in May, above projections of 80,000. Following the news, Treasury yields jumped as anticipation of changes in Federal Reserve policy grew, with the 10-year yield rising above 4.5% and the 30-year yield surpassing 5%.

The S&P 500 is down more than 2% for the week, on course for its first weekly fall in 10 sessions. Anshul Sharma of Savvy Wealth described the drop as profit-taking, noting that even though the AI narrative remains largely intact, relatively positive news can still fall short when expectations are high. With that background, let’s explore our 12 Best Buy-the-Dip Stocks to Invest In Now.

Our Methodology

To identify relevant stocks for this article, we screened U.S.-listed companies with market capitalizations above $2 billion. We then shortlisted stocks that have delivered 1-year returns below -30%, and currently trade at a forward PEG ratio of less than 1.

We narrowed our search further to include stocks with at least 35% consensus upside potential, as of the June 10 close. In the final stage of our search, we selected 12 stocks with the greatest upside and ranked them in ascending order.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 599.2% since May 2014, beating its benchmark by 372 percentage points (see more details here).

12. Adobe Inc. (NASDAQ:ADBE)

Adobe Inc. (NASDAQ:ADBE) is one of the 12 best buy-the-dip stocks to invest in now.

On June 8, Stifel updated its financial outlook on Adobe Inc. heading into the company’s upcoming earnings release. Analyst J. Parker Lane decided to lower the firm’s price target on the shares from $400 to $350, while keeping a Buy rating on the stock.

Parker explained that it expects an organic revenue beat of roughly 1.5% alongside modest annualized recurring revenue (ARR) growth for the second quarter.  The analyst anticipates a slight uptick for both full-year revenue and the broad ARR outlook. However, looking at Adobe’s recent track record against its own guidance metrics, Parker views such a positive scenario as the base case that is already reflected in the stock price.

On June 5, Citigroup reiterated its Neutral rating on Adobe Inc. right before the company’s upcoming earnings report. The firm decided to raise its price target on the shares from $253 to $264, leading to an adjusted upside of around 14% at the current level.

Citi pointed out that a recent expansion in multiples across the broader software sector was the primary reason for this target revision. However, the firm remains quite cautious regarding Adobe’s near-term outlook heading into the print. Specifically, the analyst noted risks surrounding the company’s fiscal 2026 outlook, explaining that current freemium and AI monetization initiatives likely won’t generate enough momentum to offset a distinct lack of pricing benefits during the second half of the year.

Adobe Inc. is a global technology company that focuses on digital media and marketing solutions. It offers tools for creating, publishing, and promoting content, and for managing documents. It also operates a platform that allows businesses to measure and monetize customer experiences based on marketing, advertising, and analytics.

11. CoreWeave Inc. (NASDAQ:CRWV)

CoreWeave Inc. (NASDAQ:CRWV) is one of the 12 best buy-the-dip stocks to invest in now.

On May 28, CoreWeave Inc. announced the launch of unified agentic AI capabilities designed to create a closed feedback loop between model training and inference. This integration utilizes four core components: serverless reinforcement learning, production inference, agent observability via W&B Weave, and autonomous improvement through W&B Skills and the MCP server.

According to the company, the serverless reinforcement learning capability allows enterprises to post-train large language models for multi-turn tasks without infrastructure management overhead, reducing costs by up to 40% and accelerating training by approximately 1.4x.

Chen Goldberg, Executive Vice President of Product and Engineering, indicated that this system allows enterprises to let agents continuously improve from real-world experience. Furthermore, the platform utilizes infrastructure that recently achieved a top Platinum ranking in both SemiAnalysis ClusterMAX 1.0 and 2.0 benchmarks, alongside top rankings for inference speed and price-performance conducted by Artificial Analysis for Moonshot AI’s Kimi K2.6. Goldberg stated:

“The pace of AI has outrun the way teams build for it. Today’s tradeoff: dev cycles that can’t keep up, or shipping agents and discovering failure modes in production. Enterprises that put agents in production first and let them continuously improve from real-world experience aren’t just building more reliable AI, they’re accelerating the path to superintelligence.”

CoreWeave Inc. works as a cloud infrastructure technology company. It offers various services, which include proprietary software and cloud services used for automation, infrastructure control solutions, and data storage. Moreover, it provides model and agent development tools, GPU and CPU compute, virtual and bare metal servers pixel streaming, batch processing solutions, and more.

10. Boston Scientific Corp. (NYSE:BSX)

Boston Scientific Corp. (NYSE:BSX) is one of the 12 best buy-the-dip stocks to invest in now.

On June 4, Truist significantly decreased the price target on Boston Scientific Corp., from $85 to $64, while maintaining a Buy rating on the stock. The firm cited recent management remarks indicating that the Watchman device’s growth in the U.S. market was slowing.

Truist believes that Boston Scientific’s current valuation is still quite distant from its strong underlying financials in spite of these particular product challenges. According to Truist, the company is still projecting a strong financial profile, with a double-digit increase in EPS and at least 7% growth in top-line revenue.

Back on May 28, Goldman Sachs decreased the target price on Boston Scientific Corp. from $81 to $71. The firm maintained its Buy rating on the shares, which still offer an adjusted upside potential in excess of 45%.

Goldman Sachs also reflected on the management’s views around Watchman revenue expectations for the second and third quarters. This formed the basis for the firm’s current stance on the company.

Boston Scientific Corp. specializes in medical devices for interventional specialties such as cardiovascular, endo-surgery, and neuro-modulation. The company operates through MedSurg and Cardiovascular segments, and offers a range of devices, including biliary stent systems, electrocautery enhanced delivery systems, direct visualization systems, and single-use duodeno-scopes.

9. Intuit Inc. (NASDAQ:INTU)

Intuit Inc. (NASDAQ:INTU) is one of the 12 best buy-the-dip stocks to invest in now.

On May 28, Intuit Inc. made an announcement regarding Analytics AI, which is an inherent conversational analytics agent built into Mailchimp and is useful for connecting revenue data, audience insights, and campaign performance. Mailchimp revealed enhanced integrations with Wix, WooCommerce, and Claude, allowing for unified e-commerce data and AI-powered marketing features from within the platforms that retailers at present utilize.

According to the company, these improvements are meant to assist small and mid-sized enterprises and e-commerce brands in expanding with confidence using Mailchimp, the top AI-powered email marketing and automation platform.

On May 26, the price target on Intuit Inc. was reduced from $600 to $500 by Mizuho analyst Siti Panigrahi. The analyst maintained an Outperform rating on the stock, claiming that the company’s third financial quarter’s weakness in TurboTax was the primary cause of the after-earnings decline.

Panigrahi stated that his optimistic view of Intuit’s tax division has not changed, emphasizing the company’s durability related to long-term growth potential bolstered by TurboTax Live and the assisted tax market.

Intuit Inc. is a financial technology platform that offers financial management, compliance, payments, tax, and personal finance solutions. The company serves individuals and small businesses through a unified AI-enabled platform. Through its QuickBooks services, it delivers checking accounts, payroll solutions, time tracking, merchant payment processing, and bill pay solutions. It also offers marketing automation and CRM services through Mailchimp.

8. Chewy Inc. (NYSE:CHWY)

Chewy Inc. (NYSE:CHWY) is one of the 12 best buy-the-dip stocks to invest in now.

On June 3, while maintaining an Outperform rating on the stock, the price target on Chewy Inc. was cut down from $50 to $40 by Mizuho. Ahead of Chewy’s results, the firm reduced its projections, claiming that the consensus expectations are still too high and need to be significantly adjusted.

Mizuho also pointed out that management has already drawn attention to declining demand patterns and pressures on pet spending brought on by inflation. According to the firm, the company could possibly lower its guidance to the lower half of its preliminary FY26 guidance range.

Although Chewy still has long-term growth prospects in sectors including advertising, private-label goods, and veterinary services, the firm feels that investors are having difficulty finding short-term catalysts that could spur a comeback in the pet products market. Despite that, Mizuho’s projected price target offers an impressive upside potential in excess of 92%.

Back on May 26, Barclays reiterated an Overweight rating for Chewy Inc. while reducing the price target from $48 to $40. Barclays added that despite the fact that the company has much better forward growth expectations and EBITDA margins, its stock has declined by 50% in the past two years.

Furthermore, the current stock price factors in a high degree of negative sentiment, which ultimately establishes a highly favorable risk-to-reward profile for investors at current levels.

Chewy Inc. is an e-commerce retail business that focuses on pet-health products and services. It offers supplies, medications, treats, and food for pets through a popular “Autoship” service, which generates 70% of business revenues. It offers products from over 3,500 brands through a high-volume automated distribution network.

7. Guidewire Software Inc. (NYSE:GWRE)

Guidewire Software Inc. (NYSE:GWRE) is one of the 12 best buy-the-dip stocks to invest in now.

On June 5, Guidewire Software Inc. (GWRE) reported its third-quarter revenue of $372.5 million, which exceeded the $356.09 million consensus expectations. CEO Mike Rosenbaum stated that the company’s outstanding Q3 result highlights its confidence in the business’s tenacity and continuous momentum, setting it up for what is anticipated to be a record-breaking fourth quarter.

He continued by saying that as insurers emphasize updating core systems, shifting important business operations to Guidewire’s cloud-based platform solutions, and incorporating AI into all of their applications, the company’s approach and market position continue to appeal to them.

The same day, Citizens reduced its target price on the company from $300 to $220, which still leads to an adjusted upside potential of almost 89%. The firm, however, reiterated an Outperform rating on the stock.

The downward revision in price target is based on “mixed” results from the third quarter. However, the firm is optimistic about the prospects during the final quarter, which will be supported by the successful execution of the company’s pushed deals.

Guidewire Software Inc. offers a cloud-based platform to property and casualty (P&C) insurers around the globe. Through the platform, it provides several applications, such as PolicyCenter, ClaimCenter, and BillingCenter, that facilitate core operations for P&C insurance companies. Other offerings include Guidewire Rating Management, Guidewire InsuranceNow, Guidewire Reinsurance Management, Guidewire Client Data Management, and more.

6. Zillow Group Inc. (NASDAQ:ZG)

Zillow Group Inc. (NASDAQ:ZG) is one of the 12 best buy-the-dip stocks to invest in now.

On June 10, RBC Capital decided to reduce its price target on Zillow Group from $95 to $70, but it chose to keep an Outperform rating on the stock. RBC points out that Zillow’s enhanced market strategy continues to generate visible and durable faster-than-market growth rates, which they see as a critical piece of the overall bull case.

However, the firm also noted that tech innovations are creating headwinds. Specifically, they stated that large language model product innovation and Google, in particular, with its increasingly sophisticated agentic aggregation capabilities, are highly likely to act as an immovable overhang for digital marketplaces for the foreseeable future. The firm shared these balanced points to explain why they lowered the target while maintaining their positive rating on the shares.

On May 5, a new benchmark for industry transparency was set when Zillow Group Inc. and Realtor.com announced a partnership to expand pre-market “Preview” listings on both platforms. Both websites will allow users to examine these early-access listings without the need for certain brokerage affiliations or unique logins.

The listings, which feature prominently on both search results and emails, allow interested individuals to keep track of listings for later updates, contact the listing agent, schedule an appointment to view the property, and use the additional time to seek mortgage approval before the homes become available to the public.

According to Jeremy Wacksman, CEO of Zillow, the real estate market functions best when all buyers have similar informational access. Additionally, the transparency aspect of the agreement is in line with the core belief of the company. Both companies are committed to ensuring that buyers get access to all homes on offer, while at the same time ensuring that sellers get maximum visibility from day one.

Zillow Group Inc. is a technology-enabled platform for the real estate market, operating through websites and mobile applications. It offers marketplaces for rentals, construction, agents, and advertising of properties. Moreover, it also offers SaaS solutions for real estate transaction management. The company ensures a seamless experience for users who benefit from end-to-end real estate transaction solutions.

5. Hamilton Lane Inc. (NASDAQ:HLNE)

Hamilton Lane Inc. (NASDAQ:HLNE) is one of the 12 best buy-the-dip stocks to invest in now.

On May 22, Oppenheimer updated its outlook on Hamilton Lane Inc. after reviewing the company’s fourth-quarter numbers and noting that its year-to-date performance dropped more than the S&P’s 8.5%. The firm maintained its Outperform rating on the shares and adjusted the price target from $171 to $179. This comes after the company continued to report an unbroken string of strong quarters.

Oppenheimer also highlighted that because of clean operational results, minor margin improvements, and over 21% growth in management fees, the company saw more than 23% year-over-year jump in non-GAAP EPS. The reported figures of $1.49 for non-GAAP EPS exceeded the consensus estimates of $1.43. The firm noted that clients were putting more capital into higher fee funds, which will continue to lift revenues over time. This makes it a notable mention in recent Hamilton Lane stock analysis.

On May 22, Brennan Hawken from BMO Capital decreased the target price for Hamilton Lane Inc. from $108 to $102. The analyst upheld an Outperform rating on the shares, which still yields more than 23% upside despite the price target revision.

Hawken highlighted that Hamilton Lane’s fourth-quarter fee-related earnings surpassed expectations, driven by lower compensation expenses and higher performance revenue.

Hamilton Lane Inc. specializes in investments in businesses across different lifecycle stages. These include early-stage startups, mature or distressed companies, and more. With a preference for controlling stake, it focuses on tech-enabled companies across unique segments such as healthcare, energy, real estate, and industrials.

4. Wix.com Ltd. (NASDAQ:WIX)

Wix.com Ltd. (NASDAQ:WIX) is one of the 12 best buy-the-dip stocks to invest in now.

On June 2, Wix.com Ltd. was named an official web-building plugin partner for the launch of OpenAI’s Codex Enterprise. This integration directly links OpenAI’s agentic platform with Wix Headless, empowering users to transition from a conceptual business idea to a live, revenue-generating operation entirely within Codex.

The generated interfaces by Codex can be easily plugged into the backend services offered by Wix, using the plugin. It enables the launch of a live website that entails a customized domain, a fully configured CRM, and an active payments framework, all with only one command.

This functionality is enabled by the integration of Wix Headless and its Model Context Protocol (MCP), which sets up an important compliance and security framework for real-world AI agents. Wix manages data rules like GDPR and PCI-DSS natively at the infrastructure level, taking on the underlying operational and legal concerns.

Shahar Talmi, GM of Developer Platform at Wix, emphasized that this infrastructure ensures AI-generated storefronts can operate as fully functional and sustainable businesses at scale. Ultimately, this seamless integration eliminates the need for developers and entrepreneurs to manually stitch together disparate SaaS tools.

Wix.com Ltd. is a cloud-based web development platform that allows registered users to manage and grow their online businesses through AI-enabled tools. The company offers various services such as Wix Editor, Wix Studio Velo by Wix, Wix App Market, Wix Marketplace, and more.

3. Charter Communications Inc. (NASDAQ:CHTR)

Charter Communications Inc. (NASDAQ:CHTR) is one of the 12 best buy-the-dip stocks to invest in now.

On June 5, Charter Communications Inc.’s Spectrum brand made the announcement to expand its extensive network of fiber broadband. This will allow the company to deliver its Voice, TV, Mobile, and Internet offerings across areas that had been unserved or were minimally served. This entails 840+ additional residential and commercial customers.

The company’s Kentucky Management Area Vice President, Heather Day, reflected on the company’s multi-year ambition covering the rural sites. He attributed such ambition to massive private investment worth roughly $7 billion by the management. It clearly indicates a strong commitment towards a fiber infrastructure that would include more than 100,000 miles of additional capacity. Moreover, the management is confident about serving 1.7 million additional locations within the country, at highly efficient multi-gigabit speeds. Day stated:

“Spectrum is bringing gigabit broadband to rural communities in Indiana and across America. Our investment is providing residents and small businesses superior connectivity at highly competitive prices, backed by a team of skilled local technicians and 100% U.S.-based customer service.”

Charter Communications Inc. is a broadband connectivity company. Under the Spectrum brand umbrella, it delivers voice, mobile, internet, and video services. It offers data networking solutions to business entities, while also delivering cable TV, video on demand, and advertising services. The company also owns local news channels, regional sports networks, and extends broadband connectivity to apartments, student housing, and RV parks.

2. Summit Therapeutics Inc. (NASDAQ:SMMT)

Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the 12 best buy-the-dip stocks to invest in now.

On June 10, an underwritten public offering of common stock valued at $500 million was initiated by Summit Therapeutics Inc.. The company stated in its announcement that 100% of the shares in this proposed transaction are being offered directly by Summit. To manage and coordinate the equity issuance process, the firm has appointed J.P. Morgan, Goldman Sachs & Co., and Citigroup to serve as the joint book-running managers.

On June 1, following the presentation of Phase 3 HARMONi-6 trial data at an ASCO plenary session, Cantor Fitzgerald reaffirmed its Overweight rating on Summit Therapeutics Inc.. As a first-line treatment for squamous non-small cell lung cancer (NSCLC), the China-based research evaluated the combination of ivonescimab and chemotherapy versus tislelizumab plus chemotherapy.

The ivonescimab combination produced a median progression-free survival (PFS) of 11 months and a hazard ratio of 0.60, according to previously published results at ESMO 2025. Overall survival (OS) data were still in their infancy at the time. Cantor pointed out that worries about whether PFS enhancements will eventually result in an OS benefit in the first-line scenario are addressed by the interim OS data from HARMONi-6.

The main question at hand is whether the Phase 3 HARMONi-3 trial, which is comparing ivonescimab with chemotherapy versus pembrolizumab plus chemotherapy in first-line NSCLC, can repeat these favorable results worldwide. The second part of 2026 is when results are expected. Although the speaker acknowledged that HARMONi-6 showed efficacy in China, concerns were raised during the ASCO discussion about the regimen’s suitability for patients in the United States.

Summit Therapeutics Inc. is a clinical-stage biopharma company that develops and commercializes medical oncology therapies. It is focused on developing ivonescimab, a bispecific antibody that combines blockade of PD-1 and anti-angiogenesis in a single molecule. It is also running Phase III clinical trials for the treatment of non-small lung cancer.

1. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the 12 best buy-the-dip stocks to invest in now.

As of June 5 closing, the consensus sentiment around Ultragenyx Pharmaceutical Inc. remained strongly bullish. Based on a median one-year target price of $51.87, the stock offers more than 122% upside.

Back on May 21, Kristen Kluska from Cantor Fitzgerald increased the target price for the stock from $84 to $96, resulting in a revised upside potential of almost 312%. The analyst reiterated her Overweight rating on the stock, based on a greater statistical success probability of GTX-102 to cure Angelman syndrome. This stems from the Phase 3 design, enabling the threshold for statistical significance to be compartmentalized into 2 endpoints, i.e., MDRI and Bayley-4 cognitive raw score.

More recently, the U.S. Food and Drug Administration issued draft guidance designed to streamline the development and regulatory submission process for promising human gene therapies. After it is finalized, the framework will describe how developers can use current scientific data, public information, and established platform expertise. These include manufacturing, chemistry, and control data, as well as nonclinical and clinical outcomes.

Ultragenyx Pharmaceutical Inc., being a key player in this space, is expected to benefit from this development. This regulatory effectiveness focuses on gene therapy products that use genome editing in human somatic cells.

Ultragenyx Pharmaceutical Inc. develops novel therapies, with a focus on identifying, acquiring, and commercializing products for rare and ultra-rare genetic diseases. It has a strong emphasis on gene therapy and covers various stages of clinical trials. The company is currently going through high cash burn with the aim of turning profitable from 2027 onwards.

Follow Insider Monkey on Google News.